Samuel George A. III

Lineage Cell Therapeutics, Inc. · General Counsel and Secretary

Samuel George A. III is listed in public filings as officer: General Counsel and Secretary. This Samuel George A. III insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lineage Cell Therapeutics, Inc. (LCTX). Investors use Samuel George A. III's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Lineage Cell Therapeutics, Inc.LCTX$1.7M900k sharesGrant / ExerciseMar 5, 2026$1.7M900k shares$1.84--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Lineage Cell Therapeutics, Inc.LCTX$56k31.1k sharesGrant / ExerciseFeb 11, 2026$4.5K2.5k shares$1.80--
Lineage Cell Therapeutics, Inc.LCTX--6.1k sharesGrant / ExerciseFeb 11, 2026Disclosure amount unavailable6.1k shares----
Lineage Cell Therapeutics, Inc.LCTX$46k27.5k sharesGrant / ExerciseDec 19, 2025$10965 shares$1.68--
Lineage Cell Therapeutics, Inc.LCTX--27.6k sharesGrant / ExerciseDec 19, 2025Disclosure amount unavailable1.7k shares----
Lineage Cell Therapeutics, Inc.LCTX$398k750k sharesGrant / ExerciseMar 10, 2025$397.5K750k shares$0.53--
Lineage Cell Therapeutics, Inc.LCTX$17k25.8k sharesGrant / ExerciseFeb 11, 2025$1.6K2.4k shares$0.65--
Lineage Cell Therapeutics, Inc.LCTX--6.1k sharesGrant / ExerciseFeb 11, 2025Disclosure amount unavailable6.1k shares----
Lineage Cell Therapeutics, Inc.LCTX$13k22.2k sharesBuyNov 26, 2024$9.0K15k shares$0.60--